Dapagliflozin reverses combined postcapillary and precapillary pulmonary hypertension in a patient with advanced heart failure

Minerva Cardiol Angiol. 2024 Oct;72(5):544-545. doi: 10.23736/S2724-5683.24.06592-X. Epub 2024 May 16.

Authors

Daniele Masarone¹, Luigi Falco², Dario Catapano², Rita Gravino², Fabio Valente²

Affiliations

¹ Heart Failure Unit, Department of Cardiology, AORN Dei Colli-Monaldi Hospital, Naples, Italy - danielemasarone@gmail.com.
² Heart Failure Unit, Department of Cardiology, AORN Dei Colli-Monaldi Hospital, Naples, Italy.

PMID: 38753469
DOI: 10.23736/S2724-5683.24.06592-X

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Benzhydryl Compounds* / pharmacology
Benzhydryl Compounds* / therapeutic use
Female
Glucosides* / pharmacology
Glucosides* / therapeutic use
Heart Failure* / drug therapy
Humans
Hypertension, Pulmonary* / drug therapy
Male
Middle Aged
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Treatment Outcome

Substances

Glucosides
dapagliflozin
Benzhydryl Compounds
Sodium-Glucose Transporter 2 Inhibitors